Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

No reported Deferred Revenue figures are available to summarize.

Deferred Revenue history

Currency unavailable · from the balance sheet

No Deferred Revenue data reported for this period type.

Deferred Revenue vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Deferred Revenue for AVLN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MNKDMannKind CorporationMar 2026$11.53M USD-2.0%+106.8%1.5%
GYREGyre Therapeutics, Inc.Mar 2026$99K USD-19.5%—0.1%
INSMInsmed IncorporatedJun 2026$0 USD——0.0%
VCREVicore Pharma Holding ABJun 2026SEK 0 SEK——0.0%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-10.7%+106.8%0.0%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.